Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Catherine Hunault"'
Autor:
Sylvie Dejager, Hubert Méchin, François-André Allaert, Annie Chicoye, Catherine Hunault, Christine Moisan, Laura Romengas, Olivier Bugnon, Bruno Vergès, Yves Michiels
Publikováno v:
Advances in Therapy
Advances in Therapy, Springer Verlag (Germany), 2019, 36 (6), pp.1291-1303. ⟨10.1007/s12325-019-00957-y⟩
Advances in therapy, vol. 36, no. 6, pp. 1291-1303
Advances in Therapy, Springer Verlag (Germany), 2019, 36 (6), pp.1291-1303. ⟨10.1007/s12325-019-00957-y⟩
Advances in therapy, vol. 36, no. 6, pp. 1291-1303
Introduction Low-quality communication between patients and care providers and limited patient knowledge of the disease and the therapy are important factors associated with poor glycemic control in patients with type 2 diabetes. We conducted a multi
Autor:
Nicolas Meyer, Caroline Dutriaux, Evelyne Boos, Catherine Hunault, Philippe Saiag, Laurent Mortier, Lynda Benmahammed
Publikováno v:
Journal of Clinical Oncology. 36:9563-9563
9563Background: Advanced mucosal melanoma is a rare subgroup of tumors for which few data on immune therapeutic approaches is available as they are rarely or not included in pivotal trials. Pembrol...
Autor:
Abir Tadmouri, Nicolas Meyer, Laurent Mortier, Catherine Hunault, Caroline Dutriaux, Lynda Benmahammed, Philippe Saiag, Ouzna Morsli, Marie Thérèse Leccia
Publikováno v:
Journal of Clinical Oncology. 36:9555-9555
9555Background: Information on the use of radiotherapy in anti-PD-1 monoclonal antibody-treated melanoma pts is limited although some data support a synergistic effect. Methods: We investigated the...
Autor:
Marie Thérèse Leccia, Philippe Saiag, Laurent Mortier, Lynda Benmahammed, Nicolas Meyer, Brigitte Dréno, Evelyne Boos, Caroline Dutriaux, Catherine Hunault
Publikováno v:
Journal of Clinical Oncology. 36:e21519-e21519
e21519Background: Pembrolizumab (PBZ), a monoclonal anti-PD1 antibody, has been approved in France as a first-line treatment of patients with advanced melanoma in Oct. 2015. Although this treatment...
Autor:
Amir Khammari, Marie Thérèse Leccia, Abir Tadmouri, Nicolas Meyer, Lynda Benmahammed, Caroline Dutriaux, Laurent Mortier, Catherine Hunault, Philippe Saiag
Publikováno v:
Journal of Clinical Oncology. 36:e21508-e21508
e21508Background: Pembrolizumab (PBZ), a monoclonal anti-PD-1, is approved in France since Oct 2015, as a first-line treatment of patients with advanced melanoma. Although this treatment was shown ...
Autor:
Ivana Obradovic, Marina Varastet, Michel Rotily, Jean-Noël Marzo, Catherine Hunault, Fadi Meroueh, Adeline Zin
Publikováno v:
Addiction (Abingdon, England). 104(7)
Aims To describe the profile of imprisoned opioid-dependent patients, prescriptions of maintenance therapy at imprisonment and 3-year outcome in terms of re-incarceration and mortality. Design Prospective, observational study (France, 2003–06). Set